Delivery Order SPE2DB22D3501-SPE2DB25FVB20
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% gel-solution, a medication used to treat glaucoma. The contract has a ceiling value of $8,363.49 and runs through September 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Timolol 0.5% gel-solution. The contract has a ceiling value of $8,822.64 and a period of performance through April 25, 2023. It is a firm-fixed-price contract, with no set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.53 fixed-price delivery order is for the supply of 5mL bottles of Timolol 0.25% gel-solution, a medication used to treat glaucoma and other eye conditions. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The $1,936.67 Firm Fixed Price Delivery Order contract has an ultimate completion date of October 19, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat certain eye conditions. The contract has a ceiling value of $22,933.67 and a period of performance through February 13, 2024. The contract was awarded on a firm fixed-price basis and was not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% Gel-Solution, a medical eye drop product, with a ceiling value of $9,324.26 and an ultimate completion date of February 7, 2024. The contract is a firm fixed-price agreement, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,330.21, is for the delivery of Timolol 0.5% Gel-Solution 5ML, a medication used to treat certain types of glaucoma and high eye pressure. The contract has a period of performance through December 9, 2024 and is a firm fixed-price contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Timolol 0.5% gel-solution, a topical eye medication, in 5 ml quantities. The contract has a ceiling value of $3,393.48 and an ultimate completion date of July 23, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,136.10 firm-fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The award has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Timolol 0.5% Gel-Solution, a prescription eye medication, with a ceiling value of $6,308.29 and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....